Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
OW 2025
Factors Related to Adherence and Compliance in Patients With Overweight or Obesity Receiving Semaglutide for Weight Management
OW 2025
OW 2025
4 - 7 November 2025
Factors Related to Adherence and Compliance in Patients With Overweight or Obesity Receiving Semaglutide for Weight Management
Authors
:
Yiqiao Zhang
1
; Zhenxiang Zhao
1
; Andrea Leith
2
; Sophie Barlow
2
; Bríain Ó Hartaigh
1
Affiliations
View Details
Hide Details
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR